BELL & LINDSAY, INC.

Lobbying for OYE THEREPEUTICS · Pharmaceutical, development stage, company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Indiana · House · Senate · $30,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Health Issues

General Consulting and informing federal agencies and Congress on the research that OYE Therapeutics is currently doing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.